Legis Daily

Pharmacy Benefit Manager Sunshine and Accountability Act

USA118th CongressHR-2816| House 
| Updated: 12/17/2024
Diana Harshbarger

Diana Harshbarger

Republican Representative

Tennessee

Cosponsors (7)
Abigail Davis Spanberger (Democratic)Mariannette Miller-Meeks (Republican)Thomas Massie (Republican)Raja Krishnamoorthi (Democratic)Rashida Tlaib (Democratic)Kweisi Mfume (Democratic)Tracey Mann (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Pharmacy Benefit Manager Sunshine and Accountability Act This bill expands and otherwise modifies reporting requirements for pharmacy benefit managers (PBMs). Current law requires PBMs that contract with plans under the Medicare prescription drug benefit or plans that are offered on state health insurance exchanges to report certain information regarding rebates, fees, and other related information. The bill applies these requirements to PBMs that contract with private health insurers, and it expands these requirements to include more specific information relating to prices and fees, such as rebates that the PBM receives from drug manufacturers that are not passed through to other entities and the highest and lowest rebate percentages the PBM receives among all its contracts. The bill also requires the Department of Health and Human Services to annually post the information reported by PBMs on its website.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 25, 2023
Introduced in House
Apr 25, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 28, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • April 25, 2023
    Introduced in House


  • April 25, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 28, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.

Health

Government information and archivesHealth care costs and insurancePrescription drugs

Pharmacy Benefit Manager Sunshine and Accountability Act

USA118th CongressHR-2816| House 
| Updated: 12/17/2024
Pharmacy Benefit Manager Sunshine and Accountability Act This bill expands and otherwise modifies reporting requirements for pharmacy benefit managers (PBMs). Current law requires PBMs that contract with plans under the Medicare prescription drug benefit or plans that are offered on state health insurance exchanges to report certain information regarding rebates, fees, and other related information. The bill applies these requirements to PBMs that contract with private health insurers, and it expands these requirements to include more specific information relating to prices and fees, such as rebates that the PBM receives from drug manufacturers that are not passed through to other entities and the highest and lowest rebate percentages the PBM receives among all its contracts. The bill also requires the Department of Health and Human Services to annually post the information reported by PBMs on its website.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 25, 2023
Introduced in House
Apr 25, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 28, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • April 25, 2023
    Introduced in House


  • April 25, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 28, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.
Diana Harshbarger

Diana Harshbarger

Republican Representative

Tennessee

Cosponsors (7)
Abigail Davis Spanberger (Democratic)Mariannette Miller-Meeks (Republican)Thomas Massie (Republican)Raja Krishnamoorthi (Democratic)Rashida Tlaib (Democratic)Kweisi Mfume (Democratic)Tracey Mann (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Government information and archivesHealth care costs and insurancePrescription drugs